| NCT06493578 | A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of VYN201 Gel in Subjects With Non-segmental Vitiligo. | ACTIVE_NOT_RECRUITING | PHASE2 | 2024-06-04 | 2026-01-30 | 2025-07-10 |
| NCT04927572 | Safety, Pharmacokinetics and Efficacy of FMX114 Versus Vehicle in Adults With Atopic Dermatitis | COMPLETED | PHASE1, PHASE2 | 2021-10-13 | 2022-08-09 | 2022-08-09 |
| NCT04104685 | A Study to Compare FCD105 Foam to Minocycline 3% Foam, Adapalene 0.3% Foam and Vehicle Foam. | COMPLETED | PHASE2 | 2019-09-18 | 2020-03-03 | 2020-02-28 |
| NCT03841331 | Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Chronic Pruritus of Unknown Origin | COMPLETED | PHASE2 | 2019-01-22 | 2020-01-21 | 2019-12-10 |
| NCT03743038 | A Study Comparing Two Topicals in the Treatment of Acne Vulgaris | COMPLETED | PHASE1 | 2018-11-20 | 2019-02-11 | 2019-02-11 |
| NCT03677401 | Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo Nodularis | COMPLETED | PHASE3 | 2018-08-29 | 2020-02-06 | 2020-01-09 |
| NCT03546816 | Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo Nodularis | COMPLETED | PHASE3 | 2018-05-02 | 2020-02-14 | 2020-01-14 |
| NCT03540160 | Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch) | TERMINATED | PHASE3 | 2018-03-15 | 2020-06-17 | 2020-04-08 |
| NCT03343639 | Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Plaque Psoriasis | COMPLETED | PHASE2 | 2017-11-01 | 2018-11-12 | 2018-10-23 |
| NCT03282591 | Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough | COMPLETED | PHASE2 | 2017-10-03 | 2018-09-06 | 2018-08-15 |
| NCT03276936 | A Study to Evaluate the Long-Term Safety of Topical Administration of FMX103 in the Treatment of Moderate to Severe Papulopustular Rosacea | COMPLETED | PHASE3 | 2017-09-05 | 2019-01-15 | 2019-01-03 |
| NCT03271021 | A Study to Evaluate the Efficacy and Safety of Topical Administration of FMX101 in the Treatment of Moderate-to-Severe Acne Vulgaris | COMPLETED | PHASE3 | 2017-07-17 | 2018-09-04 | 2018-09-04 |
| NCT03142451 | A Study (Study 1) to Evaluate the Safety and Efficacy of FMX103 1.5% Topical Minocycline Foam in the Treatment of Facial Papulopustular Rosacea | COMPLETED | PHASE3 | 2017-06-02 | 2018-09-28 | 2018-08-31 |
| NCT04608500 | A Study (Study 2) to Evaluate the Safety and Efficacy of FMX103 1.5% Topical Minocycline Foam in the Treatment of Facial Papulopustular Rosacea | COMPLETED | PHASE3 | 2017-06-01 | 2018-07-31 | 2018-07-02 |
| NCT02975271 | Study of the Efficacy, Safety & Tolerability of Serlopitant for Pruritus (Itch) After Burn Injury | TERMINATED | PHASE2 | 2016-11 | 2017-01-17 | 2017-01-17 |
| NCT02975206 | Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis | COMPLETED | PHASE2 | 2016-11 | 2018-02-23 | 2018-01-16 |
| NCT04070755 | Dermal Photo Allergic Skin Reaction | COMPLETED | PHASE1 | 2016-09-21 | 2016-12-18 | 2016-11-18 |
| NCT04052711 | A Randomized, Controlled Study to Evaluate the Sensitizing Potential of FMX-101 in Healthy Volunteers Using a Repeat Insult Patch Test Design | COMPLETED | PHASE1 | 2016-09-08 | 2016-12-19 | 2016-11-19 |
| NCT04064125 | Dermal Cumulative Irritant Patch Study | COMPLETED | PHASE1 | 2016-09-01 | 2016-10-28 | 2016-09-28 |
| NCT04070742 | Dermal Phototoxicity Study | COMPLETED | PHASE1 | 2016-08-17 | 2016-10-01 | 2016-09-07 |
| NCT02815267 | A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne | COMPLETED | PHASE3 | 2016-05 | 2017-10-13 | 2017-10-13 |
| NCT02815280 | A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne | COMPLETED | PHASE3 | 2016-05 | 2017-10-13 | 2017-10-13 |
| NCT02601963 | Safety and Efficacy Study of a Topical Minocycline Foam in Patients With Papulopustular Rosacea | COMPLETED | PHASE2 | 2015-09 | 2016-08 | 2016-08 |
| NCT02239731 | Safety, Tolerability and Efficacy Study of Doxycycline Foam for the Prevention of EGFRI Skin Toxicity in Cancer Patients | COMPLETED | PHASE2 | 2014-10 | 2015-10 | 2015-10 |
| NCT02250859 | A Pharmacokinetic Study of Minocycline in Male and Female Volunteers | COMPLETED | PHASE1 | 2014-09 | 2015-01 | 2014-12 |
| NCT02196324 | A Randomized Placebo-Controlled Study of the Neurokinin-1 (NK1) Receptor Antagonist Serlopitant Prurigo Nodularis (PN) | COMPLETED | PHASE2 | 2014-07-09 | 2016-06-10 | 2016-05-27 |
| NCT01951274 | VPD-737 for Treatment of Chronic Pruritus | COMPLETED | PHASE2 | 2013-10-15 | 2014-12-02 | 2014-12-02 |
| NCT01362010 | Clinical Study to Evaluate Tolerability and Safety of FXFM244 and to Monitor Clinical Effect in Acne Vulgaris Patients | COMPLETED | PHASE2 | 2012-01 | 2013-07 | 2013-06 |
| NCT01171326 | Study to Evaluate the Safety and Efficacy of Topical Minocycline FXFM244 in Impetigo Patients | COMPLETED | PHASE2 | 2010-08 | 2012-04 | 2012-03 |
| NCT01134991 | Study to Evaluate the Safety and Efficacy of Topical Minocycline FXFM244 in Rosacea Patients | TERMINATED | PHASE2 | 2010-06 | | 2014-03 |
| NCT00835718 | A Study of MK0594 in Patients With Alcohol Dependence (0594-020) | TERMINATED | PHASE2 | 2009-02-27 | 2010-03-11 | 2010-03-11 |
| NCT00290563 | Safety and Efficacy of MK0594 to Treat Overactive Bladder (0594-003) | COMPLETED | PHASE2 | 2006-02-21 | 2007-09-24 | 2007-08 |